Karyopharm Therapeutics News

Karyopharm Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Dec 5 16:39 ET

Karyopharm Therapeutics | 8-K: Current report

Dec 3 07:11 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 20 16:12 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 8 16:10 ET

Karyopharm Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 5 08:06 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 5 07:46 ET

Karyopharm Therapeutics | 8-K: Current report

Oct 31 07:46 ET

Karyopharm Therapeutics | 8-K: Current report

Sep 17 16:15 ET

Karyopharm Therapeutics | 8-K: Current report

Aug 29 16:11 ET

Karyopharm Therapeutics | 8-K: Current report

Aug 6 07:38 ET

Karyopharm Therapeutics | 8-K: Current report

May 31 08:03 ET

Karyopharm Therapeutics | S-3: Registration statement for specified transactions by certain issuers

May 30 16:48 ET

Karyopharm Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 30 16:12 ET

Karyopharm Therapeutics | 8-K: Current report

May 14 16:10 ET

Karyopharm Therapeutics | 8-K: Current report

May 8 07:53 ET

Karyopharm Therapeutics | 8-K: Current report

May 8 07:53 ET

Karyopharm Therapeutics | DEFA14A: Others

Apr 19 07:48 ET

Karyopharm Therapeutics | DEF 14A: Definitive information statements

Apr 19 07:38 ET

Karyopharm Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 8 16:43 ET

Karyopharm Therapeutics | 8-K: Current report

Feb 29 07:38 ET